We present a descriptive analysis utilizing pharmacy claims from a managed care population to quantify adherence, persistence, and switching patterns for patients initiating dabigatran.
Ann S. M. Harada, PhD, MPH
Advertisement
Articles by Ann S. M. Harada, PhD, MPH
Improving Patient Self-Management of Multiple Sclerosis Through a Disease Therapy Management Program
This study evaluated the effect of a multiple sclerosis disease therapy management program on medication adherence, therapy persistence, relapses, work productivity, and quality of life.
Advertisement
Latest Updated Articles
- Adherence, Persistence, and Switching Patterns of Dabigatran Etexilate
September 16th 2013
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
ATTR-CM Incidence, Prevalence Rose Sharply in the US
3
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
4
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
5